Last Price$1,268.6(0.3%)
Market Cap$27.1B
LTM Return on Equity (ROE)
(613.8%)
5Y avg
25,795.8%
Medical - Diagnostics & Research industry
median
(15.8%)
Stock quality & Intrinsic value
7/10
(0.3%) overvalued
Mettler-Toledo International Inc. Return on Equity (ROE)
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 15.8% | 24.4% | 29.5% | 37.4% | 28.4% | 31.3% | 34.7% | 36.2% | 34.7% | 40.9% | 54.3% | 75.7% | 76.6% | 90.1% | 111.0% | 171.4% | 338.7% | 889.3% | (1,260.6%) | (623.6%) |
Overvalued or undervalued?
Check the intrinsic value for MTD
and see if it's the right time to invest.
Mettler-Toledo International Inc. (MTD) Return on Equity (ROE) comparison analysis
General
LTM Return on Equity (ROE)
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Mettler-Toledo International Inc.MTD
(613.8%)
2.2%
12.7%
22.3%
Median Peer Set
12.8%
(1.7%)
(7.2%)
11.6%
IDEXX Laboratories, Inc.IDXX
41.5%
8.7%
25.2%
23.1%
Waters CorporationWAT
37.2%
(0.5%)
(7.9%)
21.7%
Agilent Technologies, Inc.A
21.1%
(4.7%)
5.0%
19.8%
IQVIA Holdings Inc.IQV
21.1%
2.8%
2.4%
8.9%
Quest Diagnostics IncorporatedDGX
12.8%
(6.4%)
(6.5%)
9.2%
Thermo Fisher Scientific Inc.TMO
12.8%
(4.6%)
(12.4%)
14.0%
Laboratory Corporation of America HoldingsLH
9.2%
(18.3%)
(65.8%)
3.4%
Danaher CorporationDHR
5.6%
(0.1%)
(17.9%)
16.3%
Natera, Inc.NTRA
(25.0%)
32.0%
(32.1%)
(40.2%)
Illumina, Inc.ILMN
(58.3%)
(2.9%)
4.6%
(28.0%)
MTD key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 1,482.5 5.6% | 1,594.9 7.6% | 1,793.7 12.5% | 1,973.3 10.0% | 1,728.9 (12.4%) | 1,968.2 13.8% | 2,309.3 17.3% | 2,341.5 1.4% | 2,379.0 1.6% | 2,486.0 4.5% | 2,395.4 (3.6%) | 2,508.3 4.7% | 2,725.1 8.6% | 2,935.6 7.7% | 3,008.7 2.5% | 3,085.2 2.5% | 3,717.9 20.5% | 3,919.7 5.4% | 3,788.3 (3.4%) | 3,872.4 2.2% |
| Cost of Goods Sold (COGS) | 752.2 | 804.5 | 897.6 | 980.3 | 839.5 | 931.0 | 1,091.1 | 1,100.5 | 1,096.9 | 1,127.2 | 1,043.5 | 1,072.7 | 1,151.7 | 1,251.2 | 1,267.4 | 1,284.1 | 1,546.4 | 1,611.7 | 1,547.0 | 1,546.8 |
% margin | 730.3 49.3% | 790.4 49.6% | 896.2 50.0% | 993.1 50.3% | 889.3 51.4% | 1,037.2 52.7% | 1,218.3 52.8% | 1,241.1 53.0% | 1,282.0 53.9% | 1,358.8 54.7% | 1,352.0 56.4% | 1,435.6 57.2% | 1,573.3 57.7% | 1,684.4 57.4% | 1,741.2 57.9% | 1,801.0 58.4% | 2,171.6 58.4% | 2,308.0 58.9% | 2,241.3 59.2% | 2,325.6 60.1% |
| Operating Expenses | 535.0 | 576.0 | 633.2 | 692.6 | 606.7 | 704.8 | 837.6 | 817.9 | 833.7 | 881.1 | 850.8 | 888.6 | 959.4 | 1,001.4 | 1,012.8 | 1,017.0 | 1,176.8 | 1,181.8 | 1,089.4 | 1,125.7 |
| Research & Development Expenses (R&D) | 81.9 | 82.8 | 92.4 | 102.3 | 89.7 | 97.0 | 116.1 | 112.5 | 116.3 | 123.3 | 119.1 | 120.0 | 129.3 | 141.1 | 144.0 | 140.1 | 169.8 | 177.1 | 185.3 | 189.4 |
| Selling, General & Administrative Expenses (SG&A) | 441.7 | 481.7 | 529.1 | 579.8 | 505.2 | 588.7 | 703.6 | 684.0 | 692.8 | 728.6 | 700.8 | 732.6 | 787.5 | 812.8 | 819.2 | 820.2 | 944.0 | 938.5 | 904.1 | 936.3 |
% margin | 195.3 13.2% | 214.4 13.4% | 263.0 14.7% | 300.4 15.2% | 282.6 16.3% | 336.6 17.1% | 378.3 16.4% | 423.1 18.1% | 448.4 18.8% | 477.7 19.2% | 501.2 20.9% | 546.9 21.8% | 613.9 22.5% | 683.0 23.3% | 734.6 24.4% | 797.9 25.9% | 997.8 26.8% | 1,135.5 29.0% | 1,151.9 30.4% | 1,199.9 31.0% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 37.4 | 38.6 | 43.2 | 55.4 | 0.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 25.4 | 25.1 | 20.1 | 23.2 | 22.8 | 22.7 | 24.5 | 27.5 | 28.0 | 32.8 | 34.5 | 37.4 | 38.6 | 43.2 | 55.4 | 77.4 | 74.6 |
| Pre-tax Income | 160.2 | 2,048.5 | 242.9 | 266.1 | 224.8 | 307.5 | 349.2 | 382.6 | 402.7 | 445.0 | 463.4 | 504.2 | 574.2 | 651.9 | 681.4 | 748.7 | 949.4 | 1,070.6 | 973.7 | 1,037.2 |
% effective tax rate | 51.3 32.0% | 47.3 2.3% | 64.4 26.5% | 63.3 23.8% | 52.2 23.2% | 75.4 24.5% | 79.7 22.8% | 91.8 24.0% | 96.6 24.0% | 106.8 24.0% | 110.6 23.9% | 119.8 23.8% | 198.3 34.5% | 139.2 21.4% | 120.3 17.7% | 146.0 19.5% | 180.4 19.0% | 198.1 18.5% | 185.0 19.0% | 174.1 16.8% |
% margin | 108.9 7.3% | 157.5 9.9% | 178.5 10.0% | 202.8 10.3% | 172.6 10.0% | 232.1 11.8% | 269.5 11.7% | 290.8 12.4% | 306.1 12.9% | 338.2 13.6% | 352.8 14.7% | 384.4 15.3% | 376.0 13.8% | 512.6 17.5% | 561.1 18.6% | 602.7 19.5% | 769.0 20.7% | 872.5 22.3% | 788.8 20.8% | 863.1 22.3% |
| EPS | 2.58 | 3.93 | 4.82 | 5.92 | 5.12 | 6.98 | 8.45 | 9.37 | 10.22 | 11.71 | 12.75 | 14.49 | 14.62 | 20.33 | 22.84 | 25.24 | 33.25 | 38.79 | 36.10 | 40.67 |
| Diluted EPS | 2.52 | 3.86 | 4.70 | 5.79 | 5.03 | 6.80 | 8.21 | 9.14 | 9.96 | 11.44 | 12.48 | 14.22 | 14.24 | 19.88 | 22.47 | 24.91 | 32.78 | 38.41 | 35.90 | 40.67 |
% margin | 252.9 17.1% | 252.0 15.8% | 300.5 16.8% | 349.0 17.7% | 290.7 16.8% | 371.1 18.9% | 418.9 18.1% | 457.1 19.5% | 481.6 20.2% | 529.2 21.3% | 554.9 23.2% | 600.0 23.9% | 684.8 25.1% | 770.5 26.2% | 812.0 27.0% | 886.0 28.7% | 1,099.9 29.6% | 1,243.5 31.7% | 1,172.3 30.9% | 1,235.1 31.9% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Mettler-Toledo International Inc.'s Return on Equity (ROE)?
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is (613.8%), based on the financial report for Dec 31, 2024 (Q4’2024). The average annual Return on Equity (ROE) for Mettler-Toledo International Inc. have been 36,048.1% over the past three years, and 27,085.6% over the past five years.
2) Is Mettler-Toledo International Inc.'s Return on Equity (ROE) Good?
As of today, Mettler-Toledo International Inc.'s Return on Equity (ROE) is (613.8%), which is lower than industry median of (15.8%). It indicates that Mettler-Toledo International Inc.'s Return on Equity (ROE) is Bad.